-
Verteporfin Beyond PDT: A Translational Stiffness Lens
2026-08-20
Verteporfin, also known as CL 318952, is more than a light-activated photosensitizer. By combining photodynamic vascular injury, cell-death phenotyping, and light-independent disruption of p62-dependent autophagosome formation, it offers translational researchers a way to study how treatment context may intersect with cancer-cell mechanics, immune vulnerability, and metastatic colonization.
-
Cyanine 3 Tyramide for Claustrum Gene Mapping
2026-08-20
Cyanine 3 Tyramide converts low-abundance molecular signals into bright, spatially resolved orange fluorescence for comparative brain research. This guide translates claustrum gene-expression findings into practical in situ hybridization, immunohistochemistry, and multiplex assay workflows with optimization and troubleshooting checkpoints.
-
Irinotecan Workflows for Colorectal Cancer Models
2026-08-19
Build more reproducible Irinotecan and CPT-11 studies with practical guidance for stock preparation, cell-based cytotoxicity, DNA damage, apoptosis, and xenograft workflows. The article also explains how lessons from topoisomerase I research can inform assay design without overstating cross-tumor evidence.
-
UTP Solution (100 mM): Assay Reliability
2026-08-19
Learn how UTP Solution (100 mM), SKU K1048, can standardize nucleotide inputs in RNA, siRNA, and cell-assay workflows without being mistaken for a direct viability reagent. This scenario-driven guide covers compatibility, stock handling, interpretation, and practical vendor selection.
-
4-MUG for Lysosomal Enzyme Activity Assays
2026-08-18
4-MUG converts β-glucosidase and β-glucocerebrosidase activity into a quantitative fluorescent signal, making it useful for lysosomal disease models, enzyme kinetics, and screening. This workflow connects functional enzyme measurements with the recent development of optimized GBA1 mRNA while emphasizing controls, pH management, and assay-specific troubleshooting.
-
Bufuralol hydrochloride in PK organoid workflows
2026-08-18
Bufuralol hydrochloride provides a practical probe for connecting β-adrenergic pharmacology with human intestinal absorption and metabolism models. When paired with hiPSC-derived organoids, it supports controlled exposure studies, transporter-aware readouts, and more translational assay design than a receptor-only workflow.
-
LLY-507: Reading SMYD2 Biology Beyond Potency
2026-08-17
LLY-507 is a selective SMYD2 inhibitor for connecting biochemical target engagement with cancer cell proliferation inhibition and fibrosis biology. This evidence-focused guide explains how to design orthogonal assays, interpret p53 methylation, and distinguish mechanism from nonspecific cytotoxicity.
-
Primidone Research Workflows for TRPM3 and RIPK1
2026-08-17
Primidone, also known as Mysoline, is a versatile research tool for separating TRPM3 channel activity, RIPK1 signaling, hPON1 inhibition, and CYP19 selectivity in the same development program. This workflow-focused guide covers concentration selection, translational dosing, assay controls, and practical troubleshooting for neurodevelopmental, ALS, and adenomyosis models.
-
YM 58483 (BTP2) SOCE Blocker Guide
2026-08-16
YM 58483, also called BTP2, is a research inhibitor of store-operated calcium entry that suppresses sustained Ca2+ influx through CRAC and TRP channel systems. Product data report nanomolar inhibition of PHA-induced IL-2 production, while a 2025 study used YM 58483 to investigate SOCE-dependent salivary gland fibrosis.
-
ABT-888 (Veliparib) Experimental Workflows
2026-08-15
ABT-888 (Veliparib) provides a selective PARP1/2 perturbation tool for testing DNA repair inhibition, chemotherapy sensitization, and radiation response. This workflow connects formulation control with combination assays in colorectal cancer, MSI tumor models, and replication-stressed ovarian cancer systems.
-
Cisplatin (CDDP) Workflows for Cancer Research
2026-08-14
Build reproducible Cisplatin workflows that connect DNA crosslinking to viability, apoptosis, ROS, and chemotherapy resistance readouts. This guide also translates a recent cholangiocarcinoma metabolism study into practical combination-testing and xenograft design choices.
-
Nilotinib Workflows for Kinase and Tumor Immunology
2026-08-14
Nilotinib (AMN-107) provides a practical way to interrogate BCR-ABL, KIT, and PDGFR signaling while opening a distinct preclinical route into tumor-immunity assays. This guide connects phosphoprotein analysis, viability testing, MHC-I measurements, and combination studies into reproducible workflows with troubleshooting guidance.
-
Sulfo-NHS-SS-Biotin for Cleavable Protein Labeling
2026-08-13
Sulfo-NHS-SS-Biotin is a water-compatible, amine-reactive reagent for labeling lysine side chains, N-terminal amines, and accessible cell-surface proteins. Its reducible disulfide spacer supports affinity capture followed by label removal, making it useful for reversible protein purification and surface-trafficking studies.
-
LTI6426–Panobinostat Combination in Myeloma
2026-08-13
The reference study shows that the orally bioavailable PDI inhibitor LTI6426 can substantially enhance low-dose panobinostat activity in multiple myeloma models, including a proteasome inhibitor-resistant setting. Its mechanistic analysis links the combination to convergent endoplasmic reticulum stress signaling and identifies ATF3, DDIT3/CHOP, and DNAJB1 as candidate pharmacodynamic biomarkers.
-
Mouse Neutrophil Cell Isolation Kit: Workflow & Uses
2026-08-12
Build fast, low-perturbation neutrophil workflows for tumor immunology, nanoparticle studies, and functional assays. This guide shows how negative selection with CS1009 can support high-purity cell recovery while preserving the phenotype needed to evaluate neutrophil-targeted mRNA therapies.